pharma.markets

  • HOME
  • Imprint

Cancer

Pivotal Phase III study shows Roche’s Tecentriq helped people with early lung cancer live longer without their disease returning

22/03/2021 MaP 0

First Phase III study to show that a cancer immunotherapy improves disease-free survival in people with resectable early stage lung cancer compared to best supportive […]

Merck Announces Leadership Change for North America and Global Innovative Medicine Franchises in Healthcare

05/02/2021 MaP 0

Merck today announced that Rehan Verjee has made the decision to leave his position as President of EMD Serono and Global Head of Innovative Medicine […]

FDA Approves TEPMETKO® as the First and Only Once-daily Oral MET Inhibitor

03/02/2021 MaP 0

….for Patients with Metastatic NSCLC with METex14 Skipping Alterations Merck today announced that the US Food and Drug Administration (FDA) has approved TEPMETKO® (tepotinib) following […]

Bayer receives approval for Nubeqa™ in China for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC)

03/02/2021 MaP 0

The Chinese National Medical Products Administration (NMPA) has approved Nubeqa™ (darolutamide) for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at […]

Europe’s Beating Cancer Plan: A new EU approach to prevention, treatment and care

03/02/2021 MaP 0

Today, on the eve of the World Cancer Day, the European Commission is presenting Europe’s Beating Cancer Plan – a main priority in the area […]

EIB provides €20 million to support RDI activities and growth at Galenicum

26/01/2021 MaP 0

The European Investment Bank (EIB) will provide €20 million to finance the research, development and innovation (RDI) programme of Galenicum, a pharmaceutical company founded in […]

Merck Announces Formation of Merck Digital Ethics Advisory Panel

08/01/2021 MaP 0

Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. Merck, a […]

NASA Science, New Airlock Heads to Space Station on SpaceX Cargo Spacecraft

07/12/2020 MaP 0

SpaceX launched its 21st commercial resupply mission to the International Space Station at 11:17 a.m. EST Dec. 6, 2020, from Launch Pad 39A at NASA’s […]

Merck and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology

03/12/2020 MaP 0

Merck and Artios today announced a global three year strategic research collaboration to discover and develop multiple precision oncology drugs. • Merck and Artios will […]

EU Commission Pharmaceutical Strategy for Europe -Affordable, accessible and safe medicines for all

01/12/2020 MaP 0

The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, […]

A stronger EU health security framework

01/12/2020 MaP 0

To create a more robust mandate for coordination by the Commission and EU agencies, the Commission is today proposing a new Regulation on serious cross-border […]

Stronger and more operational EU Medicine Agencies

01/12/2020 MaP 0

The European Centre for Disease Control and Prevention and the European Medicines Agency have been at the forefront of the EU’s work to address COVID-19 […]

Posts navigation

1 2 3 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines
  • Valencia Comunidad

Reports

  • Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents
  • Spain – The vaccination schedule: when will we be vaccinated?
  • Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months
  • IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus
  • BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

Archive

  • April 2021 (3)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents

    09/04/2021 0
  • Spain – The vaccination schedule: when will we be vaccinated?

    07/04/2021 0
  • Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months

    01/04/2021 0
  • IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus

    30/03/2021 0
  • BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

    26/03/2021 0
Archives
  • April 2021 (3)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support test vaccine

Copyright © 2021 | WordPress Theme by MH Themes